Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection ...
A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
SHE may be just 39, but recent photos of Kelly Osbourne have left even her most loyal fans stunned. Despite the daughter of Ozzy and Sharon Osbourne having changed her appearance on countless ...
Amgen stock rose moderately Thursday after Chief Financial Officer Peter Griffith said the biotech is "laser-focused" on developing its obesity treatment, MariTide.Please watch the video at Investors.
Some results have been hidden because they may be inaccessible to you